Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
28.56
+0.03 (+0.11%)
Official Closing Price
Updated: 7:00 PM EDT, May 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Pfizer
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
32
33
Next >
Follow-Up Data From Phase 3 Trial of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age
November 22, 2021
From
Pfizer Inc.
Via
Business Wire
Pfizer and BioNTech Receive Expanded U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster to Include Individuals 18 and Older
November 19, 2021
From
Pfizer Inc.
Via
Business Wire
Todos Medical Announces Completion of Enrollment for COVID-19 Oral Antiviral 3CLPro (Mpro) Inhibitor Tollovir Phase 2 Clinical Trial Interim Analysis in Severe and Critical Hospitalized Patients
November 19, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Death
Intellectual Property
Supply Chain
Exposures
COVID-19
Death
Intellectual Property
Infectious Disease Treatment Market May See Big Move : Pfizer, ABBVIE, Amgen
November 10, 2021
Stay up-to-date with Global Infectious Disease Treatment Market research offered by AMA. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Exposures
Product Safety
North America Pharmaceutical Logistics Supply Chain, Market Trends, and Forecast – Exclusive Report by Mordor Intelligence
November 18, 2021
Via
AB Newswire
Pfizer’s XELJANZ® (tofacitinib) Receives Marketing Authorization in the European Union for the Treatment of Active Ankylosing Spondylitis
November 18, 2021
From
Pfizer Inc.
Via
Business Wire
Pfizer to Provide U.S. Government with 10 Million Treatment Courses of Investigational Oral Antiviral Candidate to Help Combat COVID-19
November 18, 2021
From
Pfizer Inc.
Via
Business Wire
Pfizer Completes Acquisition of Trillium Therapeutics
November 17, 2021
From
Pfizer Inc.
Via
Business Wire
GeoVax Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress
November 17, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
COVID-19
Legal
Product Safety
Pfizer Announces Retirement of Chief Financial Officer Frank D’Amelio
November 17, 2021
From
Pfizer Inc.
Via
Business Wire
Germany's Biotech Investment Boom
November 17, 2021
Berlin, Germany -- (SBWIRE) -- 11/17/2021 -- The German biotech boom goes back many years but has recently gathered new momentum thanks to the success of the BioNTech COVID-19 vaccine. The business...
Via
SBWire
Exposures
COVID-19
Pfizer Seeks Emergency Use Authorization for Novel COVID-19 Oral Antiviral Candidate
November 16, 2021
From
Pfizer Inc.
Via
Business Wire
Update: Todos Medical Reports Third Quarter 2021 Business and Financial Results
November 16, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Death
Intellectual Property
Supply Chain
Exposures
COVID-19
Death
Intellectual Property
GeoVax Receives Notice of Allowance for Cancer Vaccine Patent
November 16, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Pfizer and The Medicines Patent Pool (MPP) Sign Licensing Agreement for COVID-19 Oral Antiviral Treatment Candidate to Expand Access in Low- and Middle-Income Countries
November 16, 2021
From
Pfizer Inc.
Via
Business Wire
Todos Medical Reports Third Quarter 2021 Business and Financial Results
November 15, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Death
Intellectual Property
Supply Chain
Exposures
COVID-19
Death
Intellectual Property
GeoVax Announces Upcoming Presentations at Scientific Conferences
November 15, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
COVID-19
Legal
Product Safety
Cross-Sector Solutions for a Sustainable Future
November 15, 2021
SOURCE: Morgan Stanley
Via
3BL Media
Topics
Climate Change
Emissions
Exposures
Climate
Audience Creation -- Audientum's Proprietary 8-Step System Set to Help Coaches Achieve 6-Figure Launches
November 12, 2021
Data-driven methodology creates fast-tracked launches and leads for entrepreneurs
Via
IssueWire
Human Growth Hormone Market In-depth Analysis | Key Players: Novo Nordisk; Pfizer Inc; Eli Lilly and Company; Sandoz International; Merck; Genentech | Grand View Research, Inc.
November 12, 2021
Via
AB Newswire
GeoVax Reports 2021 Third Quarter Financial Results and Provides Corporate Update
November 11, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
FFW Announces Partnership With Digital Asset Management Provider MediaValet
November 11, 2021
November 11, 2021 -- FFW, a global leader in developing high-impact digital experience platforms, sets clients up for sustainable digital success with MediaValet's composable architecture-optimized...
Via
24-7 Press Release
Biosimilars Market worth $44.7 billion by 2026 – Key Players are Novartis AG (Switzerland), Pfizer, Inc. (US)
November 10, 2021
Via
AB Newswire
Biosimilars Market Worth $44.7 Billion by 2026 - Size, Industry Trends, Key Players and Forecast
November 10, 2021
Northbrook, IL -- (SBWIRE) -- 11/10/2021 -- Biosimilars Market Research Report Gives in Detailed Analysis of Industry Segments, Opportunities, Growth and Size That Will Help Your Business Grow.
Via
SBWire
Topics
Intellectual Property
Exposures
Intellectual Property
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
November 10, 2021
From
Pfizer Inc.
Via
Business Wire
CytoImmune Therapeutics Appoints Renowned Oncologist and Immunologist as New Chief Executive Officer
November 10, 2021
Privately held CytoImmune Therapeutics, Inc. strengthens its team by appointing cell therapy veteran Christina Coughlin, M.D., Ph.D. as CEO
Via
Newswire.com
Healthcare Nanotechnology (Nanomedicine) Market Next Big Thing : Gilead Sciences, Pfizer, 3M
November 10, 2021
The latest independent research document on Worldwide Healthcare Nanotechnology (Nanomedicine) examine investment in Market.
Via
SBWire
Fine Chemicals Market SWOT Analysis by Key Players- Lonza, Pfizer, BASF, Albemarle
November 10, 2021
Stay up-to-date with Fine Chemicals Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Exposures
COVID-19
GeoVax and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope's COVID-19 Vaccine
November 09, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Find out Now, What Should You Do for Fast Ulcerative Colitis Market by 2027 : Key Players Are
November 09, 2021
Global Ulcerative Colitis Market has valued approximately at USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than 5.3% over the forecast period 2021-2027....
Via
SBWire
Exposures
COVID-19
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.